Comparison of the efficacy of avatrombopag and malfatrombopag

Avatrombopag and Hetrombopag are both thrombopoietic drugs that are used to treat thrombocytopenia, especially low platelets caused by chronic liver disease or chemotherapy. Both promote the production of platelets in the bone marrow by activating the thrombopoietin receptor (TPO-R), thereby reducing the risk of bleeding and improving the patient's quality of life. Although their mechanisms of action are similar, they have certain differences in indications, pharmacokinetics and clinical applications.

Avatrombopag is primarily approved for use in patients with thrombocytopenia due to chronic liver disease, specifically to increase platelet counts and reduce the risk of bleeding before undergoing invasive surgery or procedures. The drug is administered orally, has high bioavailability, is not affected by food, is easy to use, and clinical studies have shown that it is safe and has fewer side effects. Avatrombopag is faster in promoting platelet recovery and is suitable for patients who need to quickly increase platelets in the short term.

Malfatrombopag is also an oral thrombopoietin receptor agonist, and its indications cover the treatment of thrombocytopenia, especially in some countries and regions, which focus more on the management of chemotherapy-induced thrombocytopenia. Clinical data show that melfatrombopag has a significant effect in increasing platelet count, and its safety in long-term use is also guaranteed. Compared with avatrombopag, malfatrombopag may have a more flexible dosage regimen and is suitable for patients with thrombocytopenia of different causes.
Overall, although both avatrombopag and malfatrombopag are effective drugs for thrombocytopenia, avatrombopag is more focused on liver disease-related thrombocytopenia, emphasizing the rapid improvement of preoperative preparation; while malfatrombopag is more widely used in chemotherapy-related thrombocytopenia and long-term treatment. The choice of drug depends on the patient's specific condition, drug availability, and the doctor's clinical judgment. Both are oral drugs and are easy to use, but the specific efficacy and side effects should be comprehensively evaluated under the guidance of a doctor.
Reference: https://go.drugbank.com/drugs/DB11995